SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 121 filers reported holding SUTRO BIOPHARMA INC in Q2 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $35,568 | -23.5% | 10,250 | +2.5% | 0.00% | – |
| Q2 2023 | $46,500 | +0.6% | 10,000 | 0.0% | 0.00% | – |
| Q1 2023 | $46,200 | -39.8% | 10,000 | +5.3% | 0.00% | – |
| Q4 2022 | $76,760 | +1819.0% | 9,500 | +4650.0% | 0.00% | – |
| Q4 2020 | $4,000 | +100.0% | 200 | 0.0% | 0.00% | – |
| Q3 2020 | $2,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q2 2020 | $2,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q1 2020 | $2,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,824,542 | $34,466,000 | 16.86% |
| Samsara BioCapital, LLC | 1,675,579 | $31,652,000 | 4.97% |
| First Light Asset Management, LLC | 2,191,439 | $41,396,000 | 2.73% |
| FRAZIER MANAGEMENT LLC | 1,468,663 | $27,743,000 | 2.22% |
| AJU IB Investment Co., Ltd. | 175,000 | $3,306,000 | 2.13% |
| Opaleye Management Inc. | 537,800 | $10,159,000 | 1.90% |
| Parkman Healthcare Partners LLC | 163,389 | $3,086,000 | 0.78% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,233,695 | $42,194,000 | 0.71% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 139,331 | $2,629,000 | 0.63% |
| BVF INC/IL | 826,825 | $15,619,000 | 0.61% |